Bosch Packaging opens new manufacturing facility in India
The 33,000ft² facility is designed to fulfill capacity expansion and meet the increasing demand of India’s packaging market as well as international markets. Bosch managing director V K
The US Food and Drug Administration (FDA) has approved AstraZeneca’s Imfinzi (durvalumab) in combination with Padcev (enfortumab vedotin) for adult patients with muscle-invasive bladder cancer (MIBC) who cannot receive or have refused cisplatin-based chemotherapy.
Synthetic Biologics leverages Intrexon’s suite of proprietary technologies for the discovery of fully human mAbs for the treatment of certain infectious diseases not adequately addressed by existing therapies.